Notable Downgrades: Everyday Health (EVDY), WebMD Health Corp. (WBMD), Broadcom (BRCM), Illumina (ILMN)

Analysts at Stifel downgraded Everyday Health, Inc. (EVDY) from ‘Buy’ to ‘Hold’ in a research report issued to clients on Thursday. The firm believes that salesforce issues in Q315 will continue to negatively impact the company in FY 2016.

On valuation measures, Everyday Health Inc stock it’s trading at a forward P/E multiple of 7.40x, and at a multiple of 81.66x this year’s estimated earnings. The t-12-month revenue at Everyday Health is $213.34 million. EVDY ‘s ROE for the same period is 1.34%.

Everyday Health dropped $0.87 to $4.89 in recent trading. Shares of the $158.59 million market cap company are down 59.96% year-over-year.

The chart below shows where the equity has traded over the past 52-weeks.

WebMD Health Corp. (WBMD) was downgraded from ‘Buy’ to ‘Hold’ at Stifel.

Shares have traded today between $45.98 and $51.16 with the price of the stock fluctuating between $37.57 to $51.16 over the last 52 weeks.

WebMD Health Corp. shares are currently changing hands at 39.26x this year’s forecasted earnings, compared to the industry’s 38.07x earnings multiple. Ticker has a t-12 price/sales ratio of 2.81. EPS for the same period registers at $1.28.

Shares of WebMD have gained $2.15 to $50.17 in midday trading on Thursday, giving it a market cap of roughly $1.85 billion. The stock traded as high as $51.16 in January 5, 2016.

Bernstein reported on Thursday that they have lowered their rating for Broadcom Corp. (BRCM). The firm has downgraded BRCM from ‘Outperform’ to ‘Market Perform’.

Broadcom Corp. recently traded at $54.66, a loss of $0.68 over Wednesday’s closing price. The name has a current market capitalization of $33.29 billion.

As for passive income investors, the company pays shareholders $0.56 per share annually in dividends, yielding 0.97%. Five year average dividend yield currently stands at 1.16%.

Illumina Inc. (ILMN) had its rating lowered from ‘Outperform’ to ‘Market Perform’ by analysts at Wells Fargo (WFC) on Thursday.

Currently there are 13 analysts that rate ILMN a ‘Buy’ versus 9 rating it a ‘Hold’. No analyst rates the name a ‘Sell’.

ILMN was down $8.75 at $168.81 in midday trade, moving within a 52-week range of $130.00 to $242.37. The name, valued at $24.71 billion, opened at $170.90.

Be the first to comment

Leave a Reply

Your email address will not be published.


*